92 related articles for article (PubMed ID: 12005110)
21. Is the significant superiority of escitalopram compared with other antidepressants clinically relevant?
Montgomery SA; Möller HJ
Int Clin Psychopharmacol; 2009 May; 24(3):111-8. PubMed ID: 19357527
[TBL] [Abstract][Full Text] [Related]
22. Effective dose of escitalopram in moderate versus severe DSM-IV major depression.
Bech P; Andersen HF; Wade A
Pharmacopsychiatry; 2006 Jul; 39(4):128-34. PubMed ID: 16871468
[TBL] [Abstract][Full Text] [Related]
23. Reboxetine plus citalopram for refractory depression not responding to venlafaxine: possible mechanisms.
Dursun SM; Devarajan S
Psychopharmacology (Berl); 2001 Feb; 153(4):497-8. PubMed ID: 11243498
[No Abstract] [Full Text] [Related]
24. Cost-effectiveness of escitalopram vs. citalopram in major depressive disorder.
Fantino B; Moore N; Verdoux H; Auray JP
Int Clin Psychopharmacol; 2007 Mar; 22(2):107-15. PubMed ID: 17293711
[TBL] [Abstract][Full Text] [Related]
25. Improvement of Escitalopram-Induced Sweating With Citalopram.
Kolli V; Rainville CT
Prim Care Companion CNS Disord; 2017 Apr; 19(2):. PubMed ID: 28426928
[No Abstract] [Full Text] [Related]
26. Pharmacological augmentation of motor recovery after stroke: antidepressants for non-depressed patients?
Tallelli P; Werring DJ
J Neurol; 2009 Jul; 256(7):1159-60. PubMed ID: 19271104
[TBL] [Abstract][Full Text] [Related]
27. The effect of escitalopram on sleep problems in depressed patients.
Lader M; Andersen HF; Baekdal T
Hum Psychopharmacol; 2005 Jul; 20(5):349-54. PubMed ID: 15912558
[TBL] [Abstract][Full Text] [Related]
28. Escitalopram in clinical practice: results of an open-label trial in outpatients with depression in a naturalistic setting in Germany.
Möller HJ; Langer S; Schmauss M
Pharmacopsychiatry; 2007 Mar; 40(2):53-7. PubMed ID: 17447173
[TBL] [Abstract][Full Text] [Related]
29. [Severe forms of depression: the efficacy of escitalopram].
Spadone C
Encephale; 2009 Apr; 35(2):152-9. PubMed ID: 19393384
[TBL] [Abstract][Full Text] [Related]
30. [Efficacy of escitalopram and severity of depression: new data].
Spadone C
Encephale; 2009 Dec; 35(6):577-85. PubMed ID: 20004289
[TBL] [Abstract][Full Text] [Related]
31. The STAR*D trial: the 300 lb gorilla is in the room, but does it block all the light?
Hatcher S
Evid Based Ment Health; 2008 Nov; 11(4):97-9. PubMed ID: 18952951
[No Abstract] [Full Text] [Related]
32. Reversible escitalopram-induced hypothyroidism.
Eker SS; Akkaya C; Ersoy C; Sarandol A; Kirli S
Gen Hosp Psychiatry; 2010; 32(5):559.e5-7. PubMed ID: 20851281
[TBL] [Abstract][Full Text] [Related]
33. Are newer antidepressants really "better tolerated"?
Robinson MJ
Can J Psychiatry; 2001 Apr; 46(3):286-7. PubMed ID: 11320685
[No Abstract] [Full Text] [Related]
34. Citalopram-induced diplopia.
Dorell K; Cohen MA; Huprikar SS; Gorman JM; Jones M
Psychosomatics; 2005; 46(1):91-3. PubMed ID: 15765832
[No Abstract] [Full Text] [Related]
35. A retrospective study of citalopram in adolescents with depression.
Bostic JQ; Prince J; Brown K; Place S
J Child Adolesc Psychopharmacol; 2001; 11(2):159-66. PubMed ID: 11436955
[TBL] [Abstract][Full Text] [Related]
36. Curvaceous model of recovery from depression.
Livingston MG; Clark A
Lancet; 1997 Feb; 349(9050):447. PubMed ID: 9040570
[No Abstract] [Full Text] [Related]
37. [Clinical efficacy and achievement of a complete remission in depression: increasing interest in treatment with escitalopram].
Favré P
Encephale; 2012 Feb; 38(1):86-96. PubMed ID: 22381728
[TBL] [Abstract][Full Text] [Related]
38. Analysis of curative effect of fluoxetine and escitalopram in the depression treatment based on clinical observation.
Xiaoling Z; Yunping H; Yingdong L
Pak J Pharm Sci; 2018 May; 31(3(Special)):1115-1118. PubMed ID: 29737292
[TBL] [Abstract][Full Text] [Related]
39. Ghrelin, paraoxonase and arylesterase levels in depressive patients before and after citalopram treatment.
Barim AO; Aydin S; Colak R; Dag E; Deniz O; Sahin I
Clin Biochem; 2009 Jul; 42(10-11):1076-81. PubMed ID: 19272368
[TBL] [Abstract][Full Text] [Related]
40. Escitalopram versus placebo in the treatment of dysthymic disorder.
Hellerstein DJ; Batchelder ST; Hyler S; Arnaout B; Toba C; Benga I; Gangure D
Int Clin Psychopharmacol; 2010 May; 25(3):143-8. PubMed ID: 21811192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
